This memo is to inform you that CaviWipes has been added to the EPA’s List N1 as of the date of this memo. The CDC’s Interim Infection Prevention and Control recommendation refers to the EPA’s List N that lists EPA-registered disinfectants products for use against SARS-CoV-22.
On Friday, June 19, 2020, the FDA released a warning advising consumers not to use hand sanitizers that contain methanol and identified nine toxic hand sanitizers (see attachment) since methanol, when in contact with the skin or ingested, can cause severe health effects.
Orange, CA – 06/04/2020 – Metrex Research, LLC has been awarded a group purchasing agreement for High Level Disinfectant and Intermediate Level Disinfectant Wipes with Premier.
With testing protocols for disinfectant efficacy against SARS-CoV-2 recently approved and validated by the EPA and 3rd party testing labs, Metrex will be among the first to be testing our disinfectant product lines for efficacy against SARS-CoV-2 for submission to the EPA for approval.
Due to the global urgent need at medical facilities driven by the outbreak of the COVID-19 pandemic, we are experiencing record demand during this time.
As of the date of this writing, there is currently no EPA recognized test protocol to evaluate disinfection efficacy against this specific novel coronavirus virus strain, SARS-COV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), which causes COVID-19 (Coronavirus Disease 2019).
As of the date of this writing, there is currently no EPA recognized test protocol to evaluate disinfection efficacy against this specific novel coronavirus virus strain, SARS-COV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), which causes COVID-19 (Coronavirus Disease 2019).
This update is in response to the recent outbreak of the 2019 Novel Coronavirus or “2019-nCoV” by the U.S. Center of Disease Control (CDC), in Wuhan, China.
